2024 Grtx earnings report

Grtx earnings report

Author: htir

August undefined, 2024

WebApr 12, 2024 · Raytheon Technologies' (NYSE:RTX) stock is up by 3.9% over the past month. Given that the markets usually pay for the long-term financial health of a company, we wonder if the current momentum in ... WebMar 10, 2024 · Galera Therapeutics, Inc. (GRTX) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Earnings Press Release 10-K Annual Report 10-K YoY Changes Annual Proxy Galera Therapeutics, Inc. CIK: 1563577 Ticker: GRTX Exhibit 99.1 Galera Reports Fourth Quarter and Full Year 2024 Financial Results …

Raytheon Technologies Corporation

WebGalera Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.297; its P/E ratio is -1.17; Galera Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials. Dec 22. Sep 22. WebApr 14, 2024 · Balentine LLC increased its position in Raytheon Technologies Co. (NYSE:RTX – Get Rating) by 32.0% in the 4th quarter, according to its most recent filing … brown messy side swoop roblox hair id

Galera Therapeutics (GRTX) Stock Price & Analysis

WebThe latest price target for Galera Therapeutics ( NASDAQ: GRTX) was reported by Piper Sandler on Tuesday, February 21, 2024. The analyst firm set a price target for 6.00 expecting GRTX to rise... WebMar 15, 2024 · GRTX Complete Galera Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebEarnings estimates and surprises for Galera Therapeutics Inc (GRTX) are an important tool used to evaluate the company's overall strength and value of the stock. ... My Custom Reports. Watchlist Emails Portfolio Emails Screener Emails End-of … brown merrell shoes

Earnings report for Galera Therapeutics, Inc. [GRTX]

GRTX - Galera Therapeutics Stock Earnings Estimates - Barchart.com

WebFind the latest Earnings Report Date for GTX Corp (GTXO) at Nasdaq.com. WebMar 8, 2024 · 8, 2024 – Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced financial results for the fourth quarter and year ended December 31, 2024 … every now and then lyrics mac davisWebGalera Therapeutics (GRTX) reports earnings on 6/7/2024. Shares are up 34.8% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the … every now and then ne demek

"WebCreate a FREE account to see full GRTX report Create My Free Account. View Sample Report. GRTX Fundamental Analysis. ... GRTX Price, Volume, Earnings, and Dividend Date. Last Price $2.81; Previous Close $2.70 Change $0.11; Open $2.74; Volume 734,211; Avg. Volume (100-day) 459,501; " - Grtx earnings report

Grtx earnings report

Galera Therapeutics, Inc. (GRTX) - Yahoo Finance

WebApr 12, 2024 · When is Galera Therapeutics' earnings announcement? View the latest GRTX earnings date, analysts forecasts, earnings history, and conference call transcripts.

Did you know?

WebMar 17, 2024 · Galera Therapeutics ( GRTX) is scheduled to report earnings on May 15, 2024. The last reported earnings were for reported on March 8, 2024 for Q4. Q What … WebApr 6, 2024 · GRTX Stock Chart & Stats Advanced Chart > $2.56 $0.12 (4.92%) At close: Mar 31 4:00 PM EDT ― Day’s Range $0 - $0 52-Week Range $1.12 - $2.84 Previous …

WebMar 17, 2024 · NASDAQ: GRTX Galera Therapeutics, Inc. Stock Earnings Report Current P/E ratio: -0.683 Price (Mar 17, 2024, EOD): $2.20 (Find current average P/E ratios for all sectors below ) GRTX Upcoming Earnings Currently no data available. GRTX Analysts Price Targets Currently no data available. About Galera Therapeutics, Inc. Web1 day ago · Below is Validea's guru fundamental report for RAYTHEON TECHNOLOGIES CORP (RTX). Of the 22 guru strategies we follow, RTX rates highest using our Growth Investor model based on the published ...

WebApr 14, 2024 · Balentine LLC increased its position in Raytheon Technologies Co. (NYSE:RTX – Get Rating) by 32.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 10,598 shares of the company’s stock after purchasing an additional 2,571 shares during the period. Balentine LLC’s holdings in Raytheon … WebGRTX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (03/15/23) Shares Sold Short 803,647 Change from Last 20.31% Percent of Float 2.39% Stock...

WebPrice To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Galera Therapeutics (GRTX)

Web20 hours ago · Earnings Summary. For their last quarter, Galera Therapeutics (GRTX) reported earnings of -$0.58 per share, missing the Zacks Consensus Estimate of -$0.50 … every now and then meaning in teluguWebMar 21, 2024 · Galera Therapeutics, Inc. (GRTX) latest earnings report: revenue, EPS, surprise, history, news and analysis. Galera Therapeutics, Inc. (GRTX) Earnings Report … every now and then meaning in urduWebMar 10, 2024 · Galera Therapeutics, Inc. (GRTX) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024. Home. SEC Filings. Galera Therapeutics, … brown metal frame glassesWebGRTX.US Galera Therapeutics Inc. Analyst Estimates & Rating – WSJ Galera Therapeutics Inc. GRTX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/20/23 $2.19 USD -0.01 -0.45%... brown metal bed frameWebOn Mar 08, 2024, Galera Therapeutics ( NASDAQ: GRTX) reported Q4 2024 earnings per share (EPS) of -$0.58, up 7.94% year over year. Total Galera Therapeutics earnings for the quarter were -$16.19 million. In the same quarter last year, Galera Therapeutics 's earnings per share (EPS) was -$0.63. brown metal floor vasesWebGalera Therapeutics Inc (GRTX) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals See More Market Capitalization, $K 114,356 Shares Outstanding, K 42,830 Annual Sales, $ 0 K Annual Income, $ -62,220 K 60-Month Beta 1.82 Price/Sales N/A Price/Cash Flow N/A … every now and then occasionallyWebGRTX.US Galera Therapeutics Inc. Analyst Estimates & Rating – WSJ Galera Therapeutics Inc. GRTX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT … brown messy fluffy hair